AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Bottom 1%
#4388 out of 4414 analysts
Average Return
-14.26%
Win Rate
30%51 out of 168
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Liquidia CorpLQDA | +176.08% | $2.55 | $7.04 | 2021-03-23 - 2022-03-22 | Buy |
Trevi Therapeutics IncTRVI | +103.97% | $2.02 | $4.11 | 2021-08-13 - 2022-08-12 | Buy |
Aerie Pharmaceuticals IncAERI | +98.43% | $7.64 | $15.16 | 2022-02-25 - 2022-08-23 | Buy |
Gw Pharmaceuticals PLCGWPH | +97.54% | $107.00 | $211.37 | 2020-02-26 - 2021-02-03 | Buy |
Gw Pharmaceuticals PLCGWPH | +93.26% | $109.37 | $211.37 | 2020-08-07 - 2021-02-03 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cormedix IncCRMD | 8 | Buy | $10.00 | +196.74% | Maintains | 15 days ago |
Heron Therapeutics IncHRTX | 10 | Buy | $4.00 | +207.69% | Maintains | 15 days ago |
Verrica Pharmaceuticals IncVRCA | 9 | Buy | $8.00 | +104.60% | Maintains | 20 days ago |
Revance Therapeutics IncRVNC | 12 | Buy | $25.00 | +260.23% | Maintains | 21 days ago |
Liquidia CorpLQDA | 12 | Buy | $18.00 | +152.10% | Reiterates | 22 days ago |
Esperion Therapeutics IncESPR | 10 | Buy | $8.00 | +529.92% | Maintains | 23 days ago |
Arcutis Biotherapeutics IncARQT | 9 | Buy | $8.00 | +321.05% | Maintains | 24 days ago |
Biocryst Pharmaceuticals IncBCRX | 5 | Buy | $12.00 | +120.99% | Reiterates | 24 days ago |
Pacira Biosciences IncPCRX | 15 | Buy | $45.00 | +66.54% | Maintains | a month ago |
Viridian Therapeutics IncVRDN | 5 | Buy | $30.00 | +82.04% | Maintains | a month ago |
Cytokinetics IncCYTK | 8 | Buy | $60.00 | +86.68% | Reiterates | a month ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Buy | $76.00 | +79.71% | Reiterates | a month ago |
Collegium Pharmaceutical IncCOLL | 16 | Buy | $36.00 | +40.68% | Maintains | 3 months ago |
Clearside Biomedical IncCLSD | 5 | Buy | $4.00 | +296.04% | Reiterates | 3 months ago |
Trevi Therapeutics IncTRVI | 8 | Buy | $8.00 | +633.94% | Reiterates | 4 months ago |
Xenon Pharmaceuticals IncXENE | 6 | Buy | $50.00 | +48.15% | Reiterates | 4 months ago |
Evolus IncEOLS | 5 | Buy | $22.00 | +131.09% | Reiterates | 4 months ago |
Kalvista Pharmaceuticals IncKALV | 7 | Buy | $22.00 | +161.28% | Reiterates | 7 months ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | +17.77% | Reiterates | 8 months ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | a year ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Flexion Therapeutics IncFLXN | 1 | Buy | $18.00 | N/A | Maintains | 2 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.